• OPEN AN ACCOUNT
Indian Indices
Sensex
76,957.27 -307.24
( -0.40%)
Global Indices
Nasdaq
53,569.16 -21.28
(-0.04%)
Dow Jones
7,731.77 -20.22
(-0.26%)
Hang Seng
66,147.06 -258.50
(-0.39%)
Nikkei 225
10,816.31 23.77
(0.22%)
Forex
USD-INR
95.48 0.22
(0.23%)
EUR-INR
111.24 0.16
(0.15%)
GBP-INR
129.74 0.04
(0.03%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
337.9869392
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
44.15
44472.92
EPS(TTM)
Face Value()
Div & Yield %
80.61
2
0.79
 

Pharmaids Pharmaceuticals reports consolidated net loss of Rs 1.81 crore in the March 2026 quarter
May 30,2026
Net Loss of Pharmaids Pharmaceuticals reported to Rs 1.81 crore in the quarter ended March 2026 as against net loss of Rs 3.94 crore during the previous quarter ended March 2025. Sales rose 50.52% to Rs 7.18 crore in the quarter ended March 2026 as against Rs 4.77 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 11.72 crore in the year ended March 2026 as against net loss of Rs 10.78 crore during the previous year ended March 2025. Sales rose 43.34% to Rs 27.88 crore in the year ended March 2026 as against Rs 19.45 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales7.184.77 51 27.8819.45 43
OPM %-4.74-81.76 --48.53-65.55 -
PBDT-0.89-4.84 82 -16.74-14.74 -14
PBT-1.37-5.46 75 -18.76-17.18 -9
NP-1.81-3.94 54 -11.72-10.78 -9